<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Avalon Globocare Corp. — News on 6ix</title>
<link>https://6ix.com/company/avalon-globocare-corp</link>
<description>Latest news and press releases for Avalon Globocare Corp. on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 21 Apr 2026 12:30:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/avalon-globocare-corp" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835450978dffbe2df0e263b.webp</url>
<title>Avalon Globocare Corp.</title>
<link>https://6ix.com/company/avalon-globocare-corp</link>
</image>
<item>
<title>Avalon Quantum AI teams up with Caylent and Amazon Web Services on Agentic AI Platform Development</title>
<link>https://6ix.com/company/avalon-globocare-corp/news/avalon-quantum-ai-teams-up-with-caylent-and-amazon-web-services-on-agentic-ai-platform-development</link>
<guid isPermaLink="true">https://6ix.com/company/avalon-globocare-corp/news/avalon-quantum-ai-teams-up-with-caylent-and-amazon-web-services-on-agentic-ai-platform-development</guid>
<pubDate>Tue, 21 Apr 2026 12:30:00 GMT</pubDate>
<description>AWS collaboration accelerates Catch-Up Phase 2 development to a fully autonomous Agentic AI Video PlatformFREEHOLD, N.J., April 21, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a technology-innovation company with a strategic focus on developing innovative products and services that serve growing consumer health and technology markets, today announced that its subsidiary, Avalon Quantum AI LLC, is collaborating with Amazon Web Services (“AWS”) to su</description>
</item>
<item>
<title>Avalon Quantum AI Announces Strategic Collaboration with Caylent, an Amazon Web Services Premier Tier Partner, to Advance its Catch-Up Product into a Fully Autonomous Agentic AI Video Platform</title>
<link>https://6ix.com/company/avalon-globocare-corp/news/avalon-quantum-ai-announces-strategic-collaboration-with-caylent-an-amazon-web-services-premier-tier-partner-to-advance-its-catch-up-product-into-a-fully-autonomous-agentic-ai-video-platform</link>
<guid isPermaLink="true">https://6ix.com/company/avalon-globocare-corp/news/avalon-quantum-ai-announces-strategic-collaboration-with-caylent-an-amazon-web-services-premier-tier-partner-to-advance-its-catch-up-product-into-a-fully-autonomous-agentic-ai-video-platform</guid>
<pubDate>Tue, 31 Mar 2026 04:00:00 GMT</pubDate>
<description>Collaboration Strengthens Development Roadmap and Supports Scalable Growth and Monetization FREEHOLD, N.J., March 31, 2026 (GLOBE NEWSWIRE) -- Avalon</description>
</item>
<item>
<title>Avalon GloboCare Announces Closing of up to $9.75 Million Private Placement Priced At-the-Market under Nasdaq Rules</title>
<link>https://6ix.com/company/avalon-globocare-corp/news/avalon-globocare-announces-closing-of-up-to-dollar975-million-private-placement-priced-at-the-market-under-nasdaq-rules</link>
<guid isPermaLink="true">https://6ix.com/company/avalon-globocare-corp/news/avalon-globocare-announces-closing-of-up-to-dollar975-million-private-placement-priced-at-the-market-under-nasdaq-rules</guid>
<pubDate>Fri, 27 Feb 2026 22:30:00 GMT</pubDate>
<description>$3.25 Million Upfront With up to Approximately $6.5 Million of Potential Aggregate Proceeds Upon the Exercise in Full of WarrantsFREEHOLD, N.J., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a diversified company focused on the development of precision diagnostic consumer products and generative AI publishing and software, today announced the closing of its previously announced private placement priced at-the-market under Nasdaq rules for th</description>
</item>
<item>
<title>Avalon GloboCare’s Subsidiary Accepted into AMD AI Developer Program to Advance Next-Generation Media Infrastructure</title>
<link>https://6ix.com/company/avalon-globocare-corp/news/avalon-globocares-subsidiary-accepted-into-amd-ai-developer-program-to-advance-next-generation-media-infrastructure</link>
<guid isPermaLink="true">https://6ix.com/company/avalon-globocare-corp/news/avalon-globocares-subsidiary-accepted-into-amd-ai-developer-program-to-advance-next-generation-media-infrastructure</guid>
<pubDate>Thu, 26 Feb 2026 13:30:00 GMT</pubDate>
<description>Strategic Access to AMD Developer Cloud Expected to Accelerate High-Performance AI Video Generation, and Future Enterprise Automation and Scalable DeploymentFREEHOLD, N.J., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a diversified company focused on the development of precision diagnostic consumer products and generative AI publishing and software, today announced that it has been accepted into the Advanced Micro Devices (“AMD”) AI Develop</description>
</item>
<item>
<title>Avalon GloboCare Announces up to $9.75 Million Private Placement Priced At-the-Market under Nasdaq Rules</title>
<link>https://6ix.com/company/avalon-globocare-corp/news/avalon-globocare-announces-up-to-dollar975-million-private-placement-priced-at-the-market-under-nasdaq-rules</link>
<guid isPermaLink="true">https://6ix.com/company/avalon-globocare-corp/news/avalon-globocare-announces-up-to-dollar975-million-private-placement-priced-at-the-market-under-nasdaq-rules</guid>
<pubDate>Thu, 26 Feb 2026 05:00:00 GMT</pubDate>
<description>$3.25 Million Upfront With up to Approximately $6.5 Million of Potential Aggregate Proceeds Upon the Exercise in Full of Warrants FREEHOLD, N.J., Feb. 26,</description>
</item>
<item>
<title>Avalon GloboCare’s Subsidiary Files Third U.S. Provisional Patent for its Catch-Up Generative AI Video Platform</title>
<link>https://6ix.com/company/avalon-globocare-corp/news/avalon-globocares-subsidiary-files-third-us-provisional-patent-for-its-catch-up-generative-ai-video-platform</link>
<guid isPermaLink="true">https://6ix.com/company/avalon-globocare-corp/news/avalon-globocares-subsidiary-files-third-us-provisional-patent-for-its-catch-up-generative-ai-video-platform</guid>
<pubDate>Wed, 18 Feb 2026 13:00:00 GMT</pubDate>
<description>Patent Covers Generation of Multiple Audience-Adaptive Commentary Video Variants While Preserving Factual IntegrityFREEHOLD, N.J., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a diversified company focused on the development of precision diagnostic consumer products and generative AI publishing and software, today announced that its subsidiary, Avalon Quantum AI LLC, has filed a new U.S. provisional patent application covering an artificial</description>
</item>
<item>
<title>Avalon GloboCare Eliminates Majority of Debentures Through $2.6 Million Conversion, Strengthening Balance Sheet, Reduces Overhang</title>
<link>https://6ix.com/company/avalon-globocare-corp/news/avalon-globocare-eliminates-majority-debentures-140000813</link>
<guid isPermaLink="true">https://6ix.com/company/avalon-globocare-corp/news/avalon-globocare-eliminates-majority-debentures-140000813</guid>
<pubDate>Mon, 02 Feb 2026 14:00:00 GMT</pubDate>
<description>Conversion Improves Capital Structure, and Reinforces Nasdaq Compliance, Enhancing Shareholder Value Company Believes That Substantially All of the Converted Shares Have Been Sold FREEHOLD, N.J., Feb. 02, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a diversified company focused on the development of precision diagnostic consumer products and generative AI publishing and software, today announced the conversion of the majority of its outstanding deb</description>
</item>
<item>
<title>Avalon GloboCare’s Subsidiary Files AI Patent Targeting Compliance-Ready Automated Video Commentary</title>
<link>https://6ix.com/company/avalon-globocare-corp/news/avalon-globocare-subsidiary-files-ai-140000373</link>
<guid isPermaLink="true">https://6ix.com/company/avalon-globocare-corp/news/avalon-globocare-subsidiary-files-ai-140000373</guid>
<pubDate>Thu, 22 Jan 2026 14:00:00 GMT</pubDate>
<description>Provisional Patent Application Covers Systems and Methods for Evidence-Constrained, Audience-Adaptive Generation of Automated Commentary VideosFREEHOLD, N.J., Jan. 22, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a diversified company focused on the development of precision diagnostic consumer products and generative AI publishing and software, today announced that its subsidiary, Avalon Quantum AI LLC, has filed a U.S. provisional patent applicatio</description>
</item>
<item>
<title>Avalon GloboCare Announces FDA Registration Renewal for KetoAir™ and Planned B2B and B2C Launch Through Catch-Up™, Its Automated Generative AI-Powered Short-Form Video SaaS Platform</title>
<link>https://6ix.com/company/avalon-globocare-corp/news/avalon-globocare-announces-fda-registration-140000966</link>
<guid isPermaLink="true">https://6ix.com/company/avalon-globocare-corp/news/avalon-globocare-announces-fda-registration-140000966</guid>
<pubDate>Tue, 20 Jan 2026 14:00:00 GMT</pubDate>
<description>FREEHOLD, N.J., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a diversified company focused on the development of precision diagnostic consumer products and generative AI publishing and software, today announced the renewal of the U.S. Food and Drug Administration (FDA) establishment registration for the KetoAir™ device by Qi Diagnostics Limited, a nanosensor-based diagnostic technologies company. Avalon markets and distributes the KetoAir™</description>
</item>
<item>
<title>Avalon GloboCare Regains Compliance with Nasdaq Stockholders’ Equity Requirement, Launches Marketing for Automated Generative AI Video Platform</title>
<link>https://6ix.com/company/avalon-globocare-corp/news/avalon-globocare-regains-compliance-nasdaq-140000670</link>
<guid isPermaLink="true">https://6ix.com/company/avalon-globocare-corp/news/avalon-globocare-regains-compliance-nasdaq-140000670</guid>
<pubDate>Mon, 12 Jan 2026 14:00:00 GMT</pubDate>
<description>FREEHOLD, N.J., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a diversified company focused on the development of precision diagnostic consumer products and the advancement of intellectual property in cellular therapy and generative AI publishing and software, today announced that it received notice from The Nasdaq Stock Market LLC (“Nasdaq”) informing the Company that it has regained compliance with the Nasdaq Capital Market’s minimum stock</description>
</item>
<item>
<title>Avalon GloboCare Board Director Highlights RPM Interactive’s Automated Generative AI Video Creation Platform in Interview with ProactiveInvestors.com</title>
<link>https://6ix.com/company/avalon-globocare-corp/news/avalon-globocare-board-director-highlights-140000324</link>
<guid isPermaLink="true">https://6ix.com/company/avalon-globocare-corp/news/avalon-globocare-board-director-highlights-140000324</guid>
<pubDate>Tue, 30 Dec 2025 14:00:00 GMT</pubDate>
<description>FREEHOLD, N.J., Dec. 30, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of precision diagnostic consumer products, today announced that Michael Mathews, a member of the Company’s Board of Directors and Chief Executive Officer of RPM Interactive, Inc. (“RPM”), participated in an interview with Proactiveinvestors.com. Recently, the Company announced that it has acquired RPM Interactive, Inc. (“RPM”), a generative artificial intelligence (“AI</description>
</item>
<item>
<title>Avalon GloboCare Acquires RPM Interactive, a Generative AI Software Company, in an All-Stock Transaction</title>
<link>https://6ix.com/company/avalon-globocare-corp/news/avalon-globocare-acquires-rpm-interactive-133000383</link>
<guid isPermaLink="true">https://6ix.com/company/avalon-globocare-corp/news/avalon-globocare-acquires-rpm-interactive-133000383</guid>
<pubDate>Mon, 15 Dec 2025 13:30:00 GMT</pubDate>
<description>Company forms a new subsidiary, Avalon Quantum AI, LLC, in connection with the acquisition Acquisition expected to resolve Nasdaq minimum stockholders’ equity deficiency RPM Interactive has developed a fully automated, generative AI powered SaaS platform for creating short-form video content FREEHOLD, N.J., Dec. 15, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of precision diagnostic consumer products, today announced that it has acquire</description>
</item>
<item>
<title>Avalon GloboCare Reports Q3 2025 Progress with KetoAir™, Holistic Health Initiatives, and International Expansion</title>
<link>https://6ix.com/company/avalon-globocare-corp/news/avalon-globocare-reports-q3-2025-140000127</link>
<guid isPermaLink="true">https://6ix.com/company/avalon-globocare-corp/news/avalon-globocare-reports-q3-2025-140000127</guid>
<pubDate>Mon, 01 Dec 2025 14:00:00 GMT</pubDate>
<description>FREEHOLD, N.J., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of precision diagnostic consumer products, today announced a series of Q3 2025 advancements for KetoAir™, including expanded deployment, the launch of a first-responder metabolic health program, and entry into an international market. Key Highlights Launched Holistic Health Reset Program with First Responders in NevadaIn August 2025, Avalon, together with Saga Health a</description>
</item>
<item>
<title>Siyata Mobile Announces Closing of Merger with Core Gaming</title>
<link>https://6ix.com/company/avalon-globocare-corp/news/siyata-mobile-announces-closing-of-merger-with-core-gaming</link>
<guid isPermaLink="true">https://6ix.com/company/avalon-globocare-corp/news/siyata-mobile-announces-closing-of-merger-with-core-gaming</guid>
<pubDate>Fri, 03 Oct 2025 15:51:00 GMT</pubDate>
<description>Siyata Mobile Inc. (Nasdaq: CHAI) ("Siyata" or the "Company"), a global developer and vendor of mission-critical Push-to-Talk over Cellular (PoC) handsets and accessories, today announced the successful completion of its previously announced merger with Core Gaming, Inc. ("Core Gaming"). The merger officially closed on October 3, 2025, marking a significant milestone in the Company's strategic transformation.</description>
</item>
<item>
<title>Avalon GloboCare to Launch Online Sales of KetoAir Breathalyzer in the United Kingdom</title>
<link>https://6ix.com/company/avalon-globocare-corp/news/avalon-globocare-launch-online-sales-130000900</link>
<guid isPermaLink="true">https://6ix.com/company/avalon-globocare-corp/news/avalon-globocare-launch-online-sales-130000900</guid>
<pubDate>Thu, 28 Aug 2025 13:00:00 GMT</pubDate>
<description>FREEHOLD, N.J., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of precision diagnostic consumer products, today announced that it will launch the sales of KetoAir™ breathalyzer device and related accessories in the United Kingdom (“UK”). The products will be available for purchase starting September 1, 2025, at www.KetoAir.uk. KetoAir™ is a handheld breathalyzer designed for ketogenic health management (U.S. Food and Drug Administ</description>
</item>
<item>
<title>Avalon GloboCare Enters into Distribution Agreement with Saga Health for KetoAir Targeting First Responders</title>
<link>https://6ix.com/company/avalon-globocare-corp/news/avalon-globocare-enters-distribution-agreement-130000254</link>
<guid isPermaLink="true">https://6ix.com/company/avalon-globocare-corp/news/avalon-globocare-enters-distribution-agreement-130000254</guid>
<pubDate>Mon, 28 Jul 2025 13:00:00 GMT</pubDate>
<description>FREEHOLD, N.J., July 28, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of precision diagnostic consumer products, today announced that its subsidiary, Q&A Distribution, LLC, has entered into a wholesale distribution agreement with Saga Health Corporation (“Saga Health”) for its use of the KetoAir™ breathalyzer device in its first responder-targeted Holistic Health Reset Program. KetoAir™ is a handheld breathalyzer designed for ketogenic h</description>
</item>
<item>
<title>Avalon GloboCare Announces Patent Issuance for Novel CAR-T and CAR-NK Cell Technology in Hong Kong</title>
<link>https://6ix.com/company/avalon-globocare-corp/news/avalon-globocare-announces-patent-issuance-120000709</link>
<guid isPermaLink="true">https://6ix.com/company/avalon-globocare-corp/news/avalon-globocare-announces-patent-issuance-120000709</guid>
<pubDate>Mon, 14 Jul 2025 12:00:00 GMT</pubDate>
<description>FREEHOLD, N.J., July 14, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of precision diagnostic consumer products, today announced the issuance of a new standard patent by the Hong Kong Intellectual Property Department (HKIPD) for its proprietary CAR-T and CAR-Natural Killer (NK) cell technology. Granted based on a Chinese patent (ZL202080015205.0) and issued as Patent No. HK40074322, the Certificate of Invention represents a significant m</description>
</item>
<item>
<title>Avalon GloboCare and Qi Diagnostics Enter into Definitive Agreement to Co-Develop Real-Time Cannabis Breathalyzer for Detecting Potential Impaired Driving</title>
<link>https://6ix.com/company/avalon-globocare-corp/news/avalon-globocare-qi-diagnostics-enter-120000600</link>
<guid isPermaLink="true">https://6ix.com/company/avalon-globocare-corp/news/avalon-globocare-qi-diagnostics-enter-120000600</guid>
<pubDate>Thu, 26 Jun 2025 12:00:00 GMT</pubDate>
<description>FREEHOLD, N.J., June 26, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of precision diagnostic consumer products, today announced that it entered into a definitive agreement with Qi Diagnostics Limited (“Qi Diagnostics”), a nanosensor-based diagnostic technologies company, to co-develop a VOC (volatile organic compound) nanosensor-based point-of-care cannabis breathalyzer. Through this strategic collaboration, Avalon, Q&A Distribution, LL</description>
</item>
<item>
<title>Avalon GloboCare Advances Proposed Merger with YOOV with Filing of Registration Statement</title>
<link>https://6ix.com/company/avalon-globocare-corp/news/avalon-globocare-advances-proposed-merger-120000710</link>
<guid isPermaLink="true">https://6ix.com/company/avalon-globocare-corp/news/avalon-globocare-advances-proposed-merger-120000710</guid>
<pubDate>Tue, 29 Apr 2025 12:00:00 GMT</pubDate>
<description>FREEHOLD, N.J., April 29, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a commercial-stage company dedicated to developing and delivering precision diagnostic consumer products, and YOOV Group Holding Limited (“YOOV”), a provider of highly advanced artificial intelligence (“AI”) automation solutions, jointly announced the filing with the U.S. Securities and Exchange Commission (“SEC”) of a registration statement on Form S-4 in connection with the pro</description>
</item>
<item>
<title>Avalon GloboCare Partners with SpecialtyHealth, Inc. to Power Police Chiefs’ Fitness Challenge with KetoAir</title>
<link>https://6ix.com/company/avalon-globocare-corp/news/avalon-globocare-partners-specialtyhealth-inc-120000986</link>
<guid isPermaLink="true">https://6ix.com/company/avalon-globocare-corp/news/avalon-globocare-partners-specialtyhealth-inc-120000986</guid>
<pubDate>Tue, 15 Apr 2025 12:00:00 GMT</pubDate>
<description>Avalon’s KetoAir™ breathalyzer used to maintain progress for law enforcement to establish and meet their BrAce goals during the ongoing BrAce 4 Impact ChallengeFREEHOLD, N.J., April 15, 2025 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a commercial-stage company dedicated to developing and delivering precision diagnostic consumer products, today announced the addition of SpecialtyHealth, Inc. (“SpecialtyHealth”) — co-founded by Dr. EJ Greenwald, the pion</description>
</item>
</channel>
</rss>